Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,705 | -32,761 | -71,804 | -53,183 | -25,673 |
| Depreciation Amortization | 5,917 | 29,028 | 22,308 | 14,813 | 7,352 |
| Accounts receivable | 7,597 | 24,318 | 10,343 | -2,681 | -17,599 |
| Accounts payable and accrued liabilities | -2,033 | -3,147 | -2,784 | -4,264 | -3,547 |
| Other Working Capital | -31,156 | 106,751 | 75,583 | 11,089 | -17,841 |
| Other Operating Activity | -4,592 | 22,113 | 5,929 | 19,539 | 28,311 |
| Operating Cash Flow | $-64,972 | $146,302 | $39,575 | $-14,687 | $-28,997 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,281 | -32,796 | -20,726 | -11,765 | -5,556 |
| Purchase Of Investment | -156,092 | -593,118 | -342,807 | -273,540 | -79,411 |
| Sale Of Investment | 186,758 | 593,259 | 468,245 | 353,171 | 167,696 |
| Investing Cash Flow | $25,385 | $-32,655 | $104,712 | $67,866 | $82,729 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -411 | -2,895 | -36,813 | -36,849 | -36,426 |
| Common Stock Issued | 371 | 3,780 | 3,479 | 2,708 | 2,134 |
| Other Financing Activity | 0 | -102,653 | 0 | 0 | 0 |
| Financing Cash Flow | $-40 | $-101,768 | $-33,334 | $-34,141 | $-34,292 |
| Exchange Rate Effect | 10 | 654 | N/A | 58 | -60 |
| Beginning Cash Position | 76,293 | 63,760 | 63,760 | 63,760 | 63,760 |
| End Cash Position | 36,676 | 76,293 | 174,713 | 82,856 | 83,140 |
| Net Cash Flow | $-39,617 | $12,533 | $110,953 | $19,096 | $19,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,972 | 146,302 | 39,575 | -14,687 | -28,997 |
| Capital Expenditure | -5,281 | -32,796 | -20,726 | -11,765 | -5,556 |
| Free Cash Flow | -70,253 | 113,506 | 18,849 | -26,452 | -34,553 |